|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Melichar B: PSA, PCA3 and the phi losophy
of prostate cancer management. Clin Chem Lab Med. 51:707–712. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Elabbady AA and Khedr MM: Extended 12-core
prostate biopsy increases both the detection of prostate cancer and
the accuracy of Gleason score. Eur Urol. 49:49–53. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Green L: Digital rectal examination
screening for prostate cancer. JAMA. 270:13151993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghai S and Toi A: Role of transrectal
ultrasonography in prostate cancer. Radiol Clin North Am.
50:1061–1073. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mohaghegh P, Karow JK, Brosh RM Jr, Bohr
VA and Hickson ID: The Bloom's and Werner's syndrome proteins are
DNA structure-specific helicases. Nucleic Acids Res. 29:2843–2849.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Böhm S and Bernstein KA: The role of
post-translational modifications in fine-tuning BLM helicase
function during DNA repair. DNA Repair (Amst). 22:123–132. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thompson ER, Doyle MA, Ryland GL, Rowley
SM, Choong DY, Tothill RW, Thorne H kConFab, Barnes DR, Li J, et
al: Exome sequencing identifies rare deleterious mutations in DNA
repair genes FANCC and BLM as potential breast cancer
susceptibility alleles. PLoS Genet. 8:e10028942012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Voer RM, Hahn MM, Mensenkamp AR,
Hoischen A, Gilissen C, Henkes A, Spruijt L, van Zelst-Stams WA,
Kets CM, Verwiel ET, et al: Deleterious germline BLM mutations and
the risk for early-onset colorectal cancer. Sci Rep. 5:140602015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Davari P, Hebert JL, Albertson DG, Huey B,
Roy R, Mancianti ML, Horvai AE, McDaniel LD, Schultz RA and Epstein
EH Jr: Loss of Blm enhances basal cell carcinoma and
rhabdomyosarcoma tumorigenesis in Ptch1+/−mice. Carcinogenesis.
31:968–973. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johnson AM, Zuhlke KA, Plotts C, McDonnell
SK, Middha S, Riska SM, Schaid DJ, Thibodeau SN, Douglas JA and
Cooney KA: Mutational landscape of candidate genes in familial
prostate cancer. Prostate. 74:1371–1378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kämpjärvi K, Kim NH, Keskitalo S, Clark
AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Mäkinen N,
Kivinummi K, et al: Somatic MED12 mutations in prostate cancer and
uterine leiomyomas promote tumorigenesis through distinct
mechanisms. Prostate. 76:22–31. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ewing CM, Ray AM, Lange EM, Zuhlke KA,
Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, et al:
Germline mutations in HOXB13 and prostate-cancer risk. N Engl J
Med. 366:141–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Douglas JA, Levin AM, Zuhlke KA, Ray AM,
Johnson GR, Lange EM, Wood DP and Cooney KA: Common variation in
the BRCA1 gene and prostate cancer risk. Cancer Epidemiol
Biomarkers Prev. 16:1510–1516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Agalliu I, Kwon EM, Zadory D, McIntosh L,
Thompson J, Stanford JL and Ostrander EA: Germline mutations in the
BRCA2 gene and susceptibility to hereditary prostate cancer. Clin
Cancer Res. 13:839–843. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kitano K: Structural mechanisms of human
RecQ helicases WRN and BLM. Front Genet. 5:3662014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ellis NA and German J: Molecular genetics
of Bloom's syndrome. Hum Mol Genet. 5:1457–1463. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schuetz JM, MaCarthur AC, Leach S, Lai AS,
Gallagher RP, Connors JM, Gascoyne RD, Spinelli JJ and
Brooks-Wilson AR: Genetic variation in the NBS1, MRE11, RAD50 and
BLM genes and susceptibility to non-Hodgkin lymphoma. BMC Med
Genet. 10:1172009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Goss KH, Risinger MA, Kordich JJ, Sanz MM,
Straughen JE, Slovek LE, Capobianco AJ, German J, Boivin GP and
Groden J: Enhanced tumor formation in mice heterozygous for Blm
mutation. Science. 297:2051–2053. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Balcı S and Aktas D: Mucinous carcinoma of
the colon in a 16-year-old Turkish boy with Bloom syndrome:
Cytogenetic, histopathologic, TP53 gene and protein expression
studies. Cancer Genet Cytogenet. 111:45–48. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Singh DK, Popuri V, Kulikowicz T, Shevelev
I, Ghosh AK, Ramamoorthy M, Rossi ML, Janscak P, Croteau DL and
Bohr VA: The human RecQ helicases BLM and RECQL4 cooperate to
preserve genome stability. Nucleic Acids Res. 40:6632–6648. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Park SJ, Lee YJ, Beck BD and Lee SH: A
positive involvement of RecQL4 in UV-induced S-phase arrest. DNA
Cell Biol. 25:696–703. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sengupta S, Robles AI, Linke SP, Sinogeeva
NI, Zhang R, Pedeux R, Ward IM, Celeste A, Nussenzweig A, Chen J,
et al: Functional interaction between BLM helicase and 53BP1 in a
Chk1-mediated pathway during S-phase arrest. J Cell Biol.
166:801–813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chester N, Kuo F, Kozak C, O'Hara CD and
Leder P: Stage-specific apoptosis, developmental delay, and
embryonic lethality in mice homozygous for a targeted disruption in
the murine Bloom's syndrome gene. Genes Dev. 12:3382–3393. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kaneko H, Fukao T, Kasahara K, Yamada T
and Kondo N: Augmented cell death with Bloom syndrome helicase
deficiency. Mol Med Rep. 4:607–609. 2011.PubMed/NCBI
|
|
26
|
Chan KL, Palmai-Pallag T, Ying S and
Hickson ID: Replication stress induces sister-chromatid bridging at
fragile site loci in mitosis. Nature Cell Biol. 11:753–760. 2009.
View Article : Google Scholar : PubMed/NCBI
|
